Each year the biotech industry gathers to discuss trends, share insights, and explore partnership opportunities at the BIO International Convention, the world’s largest meeting of its kind. The University of Pittsburgh Office of Innovation and Entrepreneurship (OIE) was well represented at this gathering of more than 6,000 industry leaders from startups to biotech giants, academia, non-profits and government entities from around the world, held earlier in June in San Diego.
We welcome our partner in the Pitt innovation and entrepreneurship ecosystem, the Clinical and Translational Sciences Institute (CTSI), for a guest post on an exciting funding opportunity to bring evidence developed in Pitt labs into a clinical setting.
Neoolife Is Pioneering Tissue Engineering Across Two Continents Revolutionizing Heart Valve Replacement with Double Component Deposition (DCD) Antonio D’Amore arrived at the University of Pittsburgh in 2008 to pursue his doctoral studies in the Department of Bioengineering with an appointment to the prestigious McGowan Institute for Regenerative Medicine.
Pitt’s Office of Industry and Economic Partnerships (OIEP) will be attending the BIO International Convention in San Diego from June 3-6, 2024. “BIO” is the largest and most comprehensive event for biotechnology business development and partnering, representing the full ecosystem of biotech with over 20,000 industry leaders attending from across the globe.
The University of Pittsburgh’s Institute for Entrepreneurial Excellence (IEE), part of the Office of Innovation and Entrepreneurship, invites small businesses and entrepreneurs across the region to explore contract opportunities with the University of Pittsburgh at its upcoming "Doing Business with Pitt" event on Friday, May 10th. This informative session, scheduled from 8:00 a.m. to 11:00 a.m. in the Connolly Ballroom in Alumni Hall on Pitt’s Oakland campus, presents a valuable opportunity to understand partnership possibilities throughout the University of Pittsburgh system.